DuPre NC, Heng Y, Raby B, Glass, Hart, Hu, Askew, Eliassen A, Hankinson S, Kraft P, et al. Involvement of fine particulate matter exposure with gene expression pathways in breast tumor and adjacent-normal breast tissue.. Environ Res. 2020;186:109535.
Publications
2020
Peng C, Heng Y, Lu D, DuPre N, Kensler K, Glass K, Zeleznik OA, Kraft P, Feldman D, Hankinson S, et al. Pre-diagnostic 25-hydroxyvitamin D concentrations in relation to tumor molecular alterations and risk of breast cancer recurrence. Cancer Epidemiol Biomarkers Prev. 2020;29(6):1253–1263.
Heng Y, Hankinson S, Wang J, Alexandrov LB, Ambrosone C, Andrade V, Brufsky A, Couch F, King T, Modugno, et al. The association of modifiable breast cancer risk factors and somatic genomic alterations in breast tumors: The Cancer Genome Atlas Network. Cancer Epidemiol Biomarkers Prev. 2020;29(3):599–605.
Wetstein S, Onken A, Luffman C, Baker G, Pyle M, Kensler K, Liu Y, Bakker B, Vlutters R, Leeuwen M, et al. Deep learning assessment of breast terminal duct lobular unit involution: towards automated prediction of breast cancer risk. PLoS ONE. 2020;15(4):e0231653.
Eismann, Heng Y, Waldschmidt J, Vlachos I, Gray, Matulonis, Konstantinopoulos P, Murphy C, Nabavi, Wulf G. Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparib. J Cancer Res Clin Oncol. 2020;146:503–514.
Zhou, Holzman, Heng Y, Kibshull, Lye S, Vazquez. EBF1 gene mRNA levels in maternal blood and spontaneous preterm birth. Reprod Sci. 2020;27(1):316–324.
2019
Baker G, Pyle M, Tobias A, Bartlett R, Phillips, Fein-Zachary V, Wulf G, Heng Y. Establishing a cohort of transgender men and gender nonconforming individuals to understand the molecular impact of testosterone on breast physiology. Transgender Health. 2019;4(1):326–330.
Tian, Rubadue C, Lin D, Veta, Pyle M, Irshad H, Heng Y. Automated Clear Cell Renal Carcinoma Grade Classification with Prognostic Significance. PLoS ONE. 2019;14(10):e0222641.
Campbell P, Ambrosone C, Nishihara, Aerts H, Bondy, Chatterjee, Garcia-Closas, Giannakis, Golden J, Heng Y, et al. Proceedings of the fourth international molecular pathological epidemiology (MPE) meeting.. Cancer Causes Control. 2019;30(8):799–811.
Wetstein SC, Onken AM, Baker GM, Pyle ME, Pluim JPW, Tamimi RM, Heng YJ, Veta M. Detection of acini in histopathology slides: towards automated prediction of breast cancer risk. In: SPIE Medical Imaging. Vols. 10956. San Diego, CA: SPIE; 2019. p. 109560Q.
Terminal duct lobular units (TDLUs) are structures in the breast which involute with the completion of childbearing and physiological ageing. Women with less TDLU involution are more likely to develop breast cancer than those with more involution. Thus, TDLU involution may be utilized as a biomarker to predict invasive cancer risk. Manual assessment of TDLU involution is a cumbersome and subjective process. This makes it amenable for automated assessment by image analysis. In this study, we developed and evaluated an acini detection method as a first step towards automated assessment of TDLU involution using a dataset of histopathological whole-slide images (WSIs) from the Nurses’ Health Study (NHS) and NHSII. The NHS/NHSII is among the world's largest investigations of epidemiological risk factors for major chronic diseases in women. We compared three different approaches to detect acini in WSIs using the U-Net convolutional neural network architecture. The approaches differ in the target that is predicted by the network: circular mask labels, soft labels and distance maps. Our results showed that soft label targets lead to a better detection performance than the other methods. F1 scores of 0.65, 0.73 and 0.66 were obtained with circular mask labels, soft labels and distance maps, respectively. Our acini detection method was furthermore validated by applying it to measure acini count per mm2 of tissue area on an independent set of WSIs. This measure was found to be significantly negatively correlated with age.